Eisspeedway

Draft:2Morrow

2Morrow, Inc.
Company typePrivate
IndustryDigital Health, Behavioral Science
Founded2011
Headquarters
Kirkland, Washington
,
U.S.
Area served
United States
Key people
  • Jo Masterson (CEO)
  • Eric Larsen (Investor Director)
  • Dr. Tamara StClaire (Board Member)
ProductsDigital therapeutics, behavior change programs
ServicesSmoking cessation, weight management, stress reduction, chronic pain management
Website2morrowinc.com

2Morrow, Inc. is an American digital health company headquartered in Kirkland, Washington. Established in 2011, the company develops mobile health programs focused on behavioral interventions, including smoking cessation, weight management, stress reduction, and chronic pain management. Its solutions are based on Acceptance and Commitment Therapy (ACT) and leverage digital therapeutics to promote behavior change.

History

2Morrow, Inc. was founded in 2011 with the goal of integrating behavioral science with mobile technology to deliver scalable health interventions.[1]

In 2014, the company released the SmartQuit app, developed in collaboration with Dr. Jonathan Bricker of the Fred Hutchinson Cancer Research Center. The app was among the first smoking cessation apps evaluated in a randomized controlled trial.[2]

In 2016, 2Morrow secured $500,000 in funding to expand the reach of SmartQuit, partnering with employers, health insurance providers, and state health departments to integrate the app into wellness programs.[3]

In 2018, the company launched a chronic pain management app as part of broader efforts to address the opioid crisis by providing non-pharmacological treatment options.[4]

In 2023, 2Morrow, Inc. was named one of the World's Best Digital Health Companies in the "Prevention" category by Newsweek.[5]

Research and Development

2Morrow has been actively involved in research to validate its digital health interventions. A study published in 2023 examined primary care providers' motivations and challenges in chronic pain management, with the goal of developing digital therapeutics tailored for primary care settings.[6]

Funding and Grants

The company has received funding from various sources, including a $250,000 grant from the Washington Life Sciences Discovery Fund in 2014 to support the development of the SmartQuit app.[7]

In 2023, 2Morrow, Inc. was awarded a $1.9 million grant from the National Institutes of Health (NIH) to develop a digital therapeutic solution for chronic pain management.[8]

Leadership

In 2020, co-founder Jo Masterson was appointed CEO to lead the company’s digital therapeutics strategy.[9]

Partnerships

2Morrow, Inc. has partnered with organizations such as Washington State Department of Health, which incorporated its smoking cessation app into state-funded quit programs.[10]

Additionally, Castlight Health has integrated 2Morrow’s digital therapeutics into its employee wellness ecosystem.[11]

References